Endo Pharma (ENDP) Completes Tender Offer for Remaining Shares of Penwest (PPCO)
Endo Pharma (Nasdaq: ENDP) today announced that it has successfully completed its tender offer by an indirect subsidiary, West Acquisition, for all the outstanding shares of Penwest Pharma (Nasdaq: PPCO).
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Bazaarvoice (BV) Agrees to Buy PowerReviews; Offers Prelim. Q1 Results, Guides Q2, FY13
- UPDATE: SAP's (SAP) America Unit to Buy Ariba (ARBA) for $45/Share
- BlackRock (BLK) Substantially Boosts Stake in Chesapeake (CHK) -CNBC's Kelly
Create E-mail Alert Related Categories
Corporate News, Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
